Genomics England extends access to datasets for researchers
[London, UK] More than 500 members of the Genomics England Clinical Interpretation Partnership (GeCIP) will be able to access the 100,000 Genomes Project dataset to carry out pioneering research.
The partnership brings together researchers, clinicians and trainees from UK and international institutions to support scientific discovery and its translation into patient care.
In June last year, Genomics England granted access to a small group of members to their Research Environment, which includes de-identified data from the 100,000 Genomes Project.
Professor Mark Caulfield, Genomics England Chief Scientist, said:
“The 100,000 Genomes Project now has the largest number of whole genomes with associated clinical data anywhere in the world.
“With the first set of GeCIP researchers being granted access to this de-identified data, we’re enabling the translation genomic research into direct patient care for years to come.”
The project, which recently reached its halfway mark, aims to have 100,000 genomes from 70,000 people with rare diseases, their families and patients with cancer sequenced by the end of 2018.
Genomics England appoints global genomics pioneer as its first CEO
Later on this year, Sir John Chisholm, Executive Chairman of Genomics England, will hand over the executive responsibility to Professor John Mattick, who will become its first CEO.
Professor Mattick will move on from his role at the Garvan Institute of Medical Research in Australia, which he transformed into one of the most renowned genomic centres in the world.
“Bringing genomics to the people will revolutionise medical research, vastly improve personal health and transform the quality and efficiency of the healthcare system, not just in the UK but around the world,” Professor Mattick added.